Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Biosyent Inc
V.RX
Alternate Symbol(s):
BIOYF
Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing...
biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(60)
•••
FormerHedgie
X
View Profile
View Bullboard History
Post by
FormerHedgie
on Nov 20, 2024 11:07am
A disciplined quarter from Rene & Co | Stock should be $16
I think the record sales with broader based growth from all lines was very encouraging. The slight decline in profitability is acceptable as the company invests in bringing its new products to
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Oct 10, 2024 10:18am
Why not acquire co.s like this?
https://www.newswire.ca/news-releases/duchesnay-pharmaceutical-group-celebrates-expansion-of-its-treatment-portfolio-for-nausea-and-vomiting-of-pregnancy-to-40-countries-around-the-world-886590560
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(60)
•••
FormerHedgie
X
View Profile
View Bullboard History
Post by
FormerHedgie
on Sep 23, 2024 5:39pm
The acquisition of Tibelia is strategically important
I was quite happy to see the announcement of Tibelia by RX. While there wasn't nearly enough financial information to determine the present value impact on Tibelia to RX what it did indicate
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Sep 20, 2024 10:46am
RE:New Press Release - BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 20, 2024 9:00am
New Press Release - BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has entered into an agreement to acquire certain assets enabling it to supply Tibelia®, a tibolone...
read article.
(92)
•••
northernman59
X
View Profile
View Bullboard History
Comment by
northernman59
on Aug 30, 2024 4:03pm
RE:BioSyent Declares Third Quarter 2024 Dividend
Love bio.my pension fund just keeps growing.love it
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 27, 2024 10:40am
RE:RE:Record qtr sales
Co's that hold a conference call to discuss earnings results must preannounce it to alert shareholders. RX does not hold CC's so no need to announce it.
(60)
•••
FormerHedgie
X
View Profile
View Bullboard History
Post by
FormerHedgie
on Aug 27, 2024 10:28am
An "unusual" but strong Q2
Like others, I had been waiting for this announcement for some time. It was unusual that the quarter was reported so late and the dividend announcemet came out before the quarter. It is
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 26, 2024 9:03pm
BioSyent Declares Third Quarter 2024 Dividend
MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend
...more
(24)
•••
overnout
X
View Profile
View Bullboard History
Comment by
overnout
on Aug 26, 2024 9:00pm
RE:Record qtr sales
Iscfa - I would be interested in your view of these results. Also, your take on announcing these results long after the market had closed without RX's tradition announcement of when results will
...more
(24)
•••
overnout
X
View Profile
View Bullboard History
Comment by
overnout
on Aug 26, 2024 8:57pm
RE:Record qtr sales
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 26, 2024 5:35pm
Record qtr sales
https://www.globenewswire.com/news-release/2024/08/26/2935832/0/en/BioSyent-Releases-Financial-Results-for-Q2-and-H1-2024.html
(24)
•••
overnout
X
View Profile
View Bullboard History
Post by
overnout
on Jul 29, 2024 3:25pm
Buyer
Wonder who bought 500,000 at $10?
(14)
•••
Farmer9
X
View Profile
View Bullboard History
Post by
Farmer9
on Jul 28, 2024 5:36pm
The next RX
RMB reminds me of RX of 17-18 years ago. Low share count and makes a profit.
(92)
•••
northernman59
X
View Profile
View Bullboard History
Comment by
northernman59
on Jul 25, 2024 8:49pm
RE:insider sale
AND?
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden